Underlying Co-Morbidity Reveals Unique Immune Signatures in Type II Diabetes Patients Infected With SARS-CoV2

BACKGROUND: SARS-CoV2 infection in patients with comorbidities, particularly T2DM, has been a major challenge globally and has been shown to be associated with high morbidity and mortality. Here, we did whole blood immunophenotyping along with plasma cytokine, chemokine, antibody isotyping, and vira...

Descripción completa

Detalles Bibliográficos
Autores principales: Sengupta, Soumya, Bhattacharya, Gargee, Chatterjee, Sanchari, Datey, Ankita, Shaw, Shubham K., Suranjika, Sandhya, Nath, Paritosh, Barik, Prakash K., Prasad, Punit, Chattopadhyay, Soma, Swain, Rajeeb K., Parida, Ajay, Devadas, Satish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094480/
https://www.ncbi.nlm.nih.gov/pubmed/35572555
http://dx.doi.org/10.3389/fimmu.2022.848335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094480/
https://www.ncbi.nlm.nih.gov/pubmed/35572555
http://dx.doi.org/10.3389/fimmu.2022.848335

Ejemplares similares